Quick Links

MRI-based biomarkers for ALS

MRI-based biomarkers for ALS

The purpose of this study is to identify possible brain or spinal cord differences in participants with ALS compared to participants without ALS. Research shows that 90 to 95 percent of ALS cases occur at random, with only 5-10 percent of ALS cases being inherited. Current MRI techniques are only partly capable of recognizing the different types of ALS. And, early stages of ALS can be similar to other more treatable disorders. This study hopes to see if there are differences on MRIs that might allow earlier diagnosis and to recognize ALS subtypes.

*Please note: this study is located in Spokane, WA*

Participant Eligibility

  • Between 18 and 80 years of age
  • Have been clinically diagnosed with early stage Amyotrophic Lateral Sclerosis (ALS)

-or-

  • Healthy control volunteer without ALS.

Contact

Lucas Sass
(208) 885-1578

Additional Study Details

Full Study Title
MRI-based biomarkers for amyotrophic lateral sclerosis

Study ID: IRB 2087
Start Date: 05/08/2017
End Date: 09/24/2020

Investigator(s)
Bryn Martin (PI)
Gregory Carter
Brian Petersen
Douglas Weeks
Michelle Wiest

Accepts Healthy Volunteers?
Yes

Study Site(s)

Inland Imaging

525 S Cowley St
Spokane, Washington 99202



Interested?

Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.

SITE PARTNERS
uw-footer